Nachrichten zur Johnson & Johnson Aktie

Johnson & Johnson: Schlechte Neuigkeiten! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Johnson & Johnson: Herber Dämpfer – Aktie unter Druck

Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit Gerichtsfällen rund um ein krebsverdächtiges Babypuder einen kräftigen Dämpfer…

Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits

NEW BRUNSWICK (dpa-AFX) - A U.S. appeals court has rejected Johnson & Johnsons bankruptcy move, saying that it cant escape…

Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits

A U.S. appeals court has rejected Johnson & Johnsons bankruptcy move, saying that it cant escape from nearly 40,000 lawsuits…

Court Rejects Johnson & Johnson Bankruptcy Strategy For 1000s Of Baby-Powder Lawsuits

Court Rejects Johnson & Johnson Bankruptcy Strategy For 1000s Of Baby-Powder Lawsuits …

Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday

The fallout from the baby powder controversy continues to damage the company....…

FEDERAL APPEALS COURT REJECTS J&J TEXAS TWO-STEP MANEUVER IN HUGE VICTORY FOR PLAINTIFFS HARMED BY J&J BABY POWDER

EAST LANSING, Mich. , Jan. 30, 2023 /PRNewswire/ -- In a huge victory for individuals grievously harmed by Johnson &…

Johnson & Johnson Shares Drop as Court Rejects Use of Bankruptcy in Talc Lawsuits

The opinion raises questions about the future of the more than 40,000 lawsuits claiming that J&J's talc products caused cancer....…

Dow Jones & Co mit Verlusten: Goldman Sachs, Kraft Heinz und CureVac stark, Tesla, Lucid, Johnson & Johnson, Nvidia, Moderna und Microsoft unter Druck – der Tag an der Wall Street

Die zuletzt freundlichen US-Aktienmärkte sind am Montag schwach in eine ereignisreiche Woche gestartet. Vor allem an der Nasdaq-Börse dominierte vor…

Johnson & Johnson stock falls Monday, underperforms market

Johnson & Johnson stock falls Monday, underperforms market...…

Johnson And Johnson Stock Slips After Missing The Mark For Earnings

Johnson and Johnsons stock took a tumble before its Q4 2022 earnings call, and the numbers reported didnt help it…

J&J Snack Foods sheds 5% after earnings fall short of expectations

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson, Chevron share losses lead Dows 261-point drop

Johnson & Johnson, Chevron share losses lead Dow's 261-point drop...…

J&J kann Babypuder-Klagen nicht vor Insolvenzgericht verhandeln lassen

Von Jonathan Randles NEW YORK (Dow Jones)--Johnson Johnson (JJ) ist mit seiner juristischen Strategie im Umgang mit Klagen…

Third Circuit Ruling Reopens Courthouse Doors for Talc-Asbestos Claims

Beasley Allen Law Firm: Controversial J&J bankruptcy ploy returned to lower court for further consideration PHILADELPHIA, Jan. 30, 2023 /PRNewswire/…

Dows 169-point fall led by losses for shares of Johnson & Johnson, Chevron

Dow's 169-point fall led by losses for shares of Johnson & Johnson, Chevron...…

Hot Stocks: JNJ, MMM fall on legal decision; GEHC rises on earnings; PHG climbs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 3-U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits

... litigation) By Tom Hals Jan 30 (Reuters) - Johnson & Johnsons strategy to use......…

Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder

NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson (JohnsonJohnson) hat im Zusammenhang mit Gerichtsfällen rund um ein…

Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder

NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…

Johnson & Johnson stock takes a dive after WSJ report that federal appeals court rejected talc bankruptcy case

Shares of Johnson & Johnson JNJ took a dive in midday trading Monday, after The Wall Street Journal reported that…

3M declines suddenly after Johnson & Johnson loses appeal on talc litigation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J falls after losing appeals court ruling in Talc litigation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment

[spotlight] Hopes for the Johnson & Johnson (J&J) Mosaico vaccine - the only HIV vaccine candidate in late-stage (Phase 3)…

Johnson & Johnson: Q4/2022 solide ausgefallen - Konsumgüter-Abspaltung "Kenvue" schreitet voran - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…

Personal care market to grow by 5.4% Y-O-Y from 2022 to 2023: Increasing number of male and female customers opting for personal care products will drive growth - Technavio

NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Personal care market Insights - Vendors: 15+, Including Amway Corp., Beiersdorf AG, CHANEL…

Johnson & Johnson stock outperforms competitors despite losses on the day

Johnson & Johnson stock outperforms competitors despite losses on the day...…

UPDATE 1-J&J says blood cancer drug improves progression-free survival in patients

...(Adds details, background) Jan 27 (Reuters) - Johnson & Johnson said......…

J&J says blood cancer drug improves progression-free survival in patients

...(Reuters) -Johnson & Johnson said on Friday an interim analysis......…

Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends

J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility....…

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Study unblinded following recommendation of Independent Data Monitoring Committee RARITAN, N.J., Jan. 27, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies…

dpa-AFX ProFeed